A groundbreaking clinical trial led by Istanbul University – Cerrahpasa aims to evaluate the potential risk of chronic postsurgical pain (CPSP) in patients undergoing cardiac implantable electronic device (CIED) implantation. This innovative study leverages an AI-driven decision support system to measure and predict pain outcomes in postoperative patients. Clinical and regulatory professionals will find this study especially relevant as it explores safer and more effective approaches to device implantation.
The trial, which is not yet recruiting, seeks to address pain measurement, chronic pain development, and associated neuropathic conditions in patients with CIEDs. The findings are expected to influence future guidelines and patient management strategies. The study’s cutting-edge focus on combining AI insights with clinical expertise highlights a forward-looking approach for the medical device community.
What is the purpose of the study?
The primary goal of this research is to examine how to better predict and assess CPSP in patients receiving CIEDs. By integrating AI-based methodologies, the study will focus on interpreting risk patterns, individual patient pain responses, and post-surgical pain trajectories. These insights are expected to improve understanding of chronic pain mechanisms associated with device implantation procedures.
How could this study impact device-related care?
CPSP is an often-overlooked complication of surgical procedures, including the implantation of CIEDs. This trial seeks to enhance patient safety and post-operative outcomes through early pain detection and management. AI-based outcome assessments have the potential to revolutionize follow-up procedures by enabling tailored therapeutic interventions for patients at higher risk of developing chronic pain.
Regulatory teams may observe significant implications as these insights could be incorporated into updated clinical guidelines. Such advancements may also introduce new risk assessment protocols for device patients, fostering higher standards of care within the industry.
What do we know about the trial so far?
Istanbul University – Cerrahpasa, a respected institution in clinical research, will oversee the study, which is sourced from ClinicalTrials.gov and is currently listed as “Not yet recruiting.” It will assess patients undergoing implantation of cardiac implantable devices, focusing on factors like neuropathic pain and other chronic conditions arising post-surgery.
Leveraging an artificial intelligence decision support system is not only an innovative choice, but it reflects the broader trends in medical device regulation where AI applications are becoming increasingly integral to evidence generation. This forward-thinking inclusion highlights the need to bridge new technologies with traditional clinical practices for greater diagnostic and therapeutic accuracy.
Frequently Asked Questions
1. What conditions will the study target?
The trial focuses on pain measurement, chronic pain, neuropathic pain, and chronic postsurgical pain related to CIED implantation.
2. Who is conducting this research?
The study is sponsored by Istanbul University – Cerrahpasa, a leading institution in clinical and medical research.
3. Is the study currently open for recruitment?
No, the study is currently listed as “Not yet recruiting” on ClinicalTrials.gov.
Conclusion
This clinical trial has significant potential to reshape how chronic postsurgical pain is assessed and managed in patients with CIEDs. By integrating advanced AI tools, researchers aim to set a new benchmark for both patient care and regulatory compliance. Clinical, quality, and regulatory teams should monitor further developments as they may influence future device-related practices and policies.
Disclaimer
This article is intended for informational purposes only and should not be construed as legal or clinical advice. Always consult relevant professionals for specific guidance.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07322900?term=medical+device